Bethesda, Md. – The National Blood Foundation has been awarded a $75,000 grant from the Coastal Blood Foundation to fund its early-career Scientific Research Grants Program.
“We are incredibly grateful for the generosity of the Coastal Blood Foundation. Support from organizations like theirs is instrumental to the success of the NBF Grants Program,” Jeanne Hendrickson, Chair of the NBF Scientific Grants Review Committee, said. “The future of blood safety and transfusion medicine research lies in the hands of the next generation of researchers.”
Since its inception, the NBF has awarded over $9 million to early-career investigators through its Scientific Research Grants Program. Many NBF early-career grant recipients have become leaders in the field. NBF awards grants for investigator-initiated original research in all aspects of blood banking, transfusion medicine, cellular therapies and patient blood management.
“We are proud to help fund important projects like this in our community,” said Jim Sebesta, chairman of the board of Coastal Blood Foundation. “The work National Blood Foundations is doing is important in directly improving the health of our region’s residents, ensuring a safe blood supply and helping in the fight against blood disorders.”
The Coastal Blood foundation was created by the merger of The Blood Alliance with nonprofit OneBlood in 2015. The merger created a more than $15 million endowment to fund the foundation and support grant recipient research, education and outreach initiatives primarily in the five-county Northeast Florida region. The organization’s goal is to manage its endowment and perpetually distribute funds to organizations performing advanced blood supply research, outreach initiatives to improve health outcomes for those with blood-related illnesses and to support related educational programs.
About the National Blood Foundation
AABB’s National Blood Foundation (NBF), established in 1983, serves the fields of transfusion medicine and cellular therapies through grant making, educational offerings and industry leadership engagement and recognition.
AABB is an international, not-for-profit association representing individuals and institutions involved in the fields of transfusion medicine and cellular therapies. The association is committed to improving health through the development and delivery of standards, accreditation and educational programs that focus on optimizing patient and donor care and safety. AABB membership includes physicians, nurses, scientists, researchers, administrators, medical technologists and other health care providers. AABB members are located in more than 80 countries and AABB accredits institutions in more than 50 countries. Learn more about AABB at www.aabb.org.